Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · IEX Real-Time Price · USD
13.20
-0.42 (-3.08%)
At close: Jul 19, 2024, 4:30 PM
13.28
+0.08 (0.61%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Mineralys Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MLYS stock has a target of 30, which predicts an increase of 127.27% from the current stock price of 13.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 2, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MLYS is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +127.27% | Apr 2, 2024 |
| Credit Suisse | Credit Suisse | Buy Maintains $38 → $37 | Buy | Maintains | $38 → $37 | +180.30% | Aug 8, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $38 | Buy | Reiterates | $38 | +187.88% | May 16, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | +187.88% | Mar 16, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 7, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.99
from -1.99
EPS Next Year
-3.16
from -2.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 174.1M | 395.7M |
| Avg | n/a | n/a | n/a | 79.6M | 211.0M |
| Low | n/a | n/a | n/a | 29.4M | 99.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 396.9% |
| Avg | - | - | - | - | 165.0% |
| Low | - | - | - | - | 24.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.72 | -2.80 | -2.68 | -3.05 | -2.45 |
| Avg | -2.99 | -3.16 | -3.38 | -4.02 | -2.54 |
| Low | -3.31 | -3.62 | -4.26 | -5.33 | -2.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.